Clinical Scorecard: Neurobehavioral Effects and Risk Factors in Survivors of Pediatric Brain Tumors
At a Glance
Category
Detail
Condition
Neurobehavioral impairments in survivors of pediatric brain tumors
Key Mechanisms
Tumor and treatment effects including cranial radiation therapy, radiation dosage, brain volume irradiated, age at treatment, genetic factors, and endocrine dysfunction
Target Population
Pediatric brain tumor survivors (PBTS) diagnosed at least two years prior and completed treatment
Care Setting
Pediatric oncology and neuropsychiatric follow-up clinics
Key Highlights
PBTS have increased risk of neurocognitive deficits including executive function impairment, attention deficits, and psychosocial difficulties.
Neurobehavioral outcomes such as ADHD, ASD-related symptoms, emotional and behavioral difficulties are prevalent but less studied.
Risk factors for neurobehavioral impairments include cranial radiation therapy parameters, age at treatment, genetic susceptibility, and endocrine dysfunction.
Guideline-Based Recommendations
Diagnosis
Diagnose ADHD and ASD based on DSM-IV or DSM-V criteria using clinical interviews by child psychiatrists, developmental behavioral pediatricians, or psychologists.
Use Autism Diagnostic Observation Schedule (ADOS) or Autism Diagnostic Interview – Revised (ADI-R) for suspected autism cases.
Use Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Scale (SWAN) for ADHD diagnostic workup.
Assess intellectual developmental disabilities (IDD) with IQ testing (WISC-IV HK) and adaptive functioning evaluation.
Management
Monitor and manage psychiatric symptoms such as depression, anxiety, and stress through multidisciplinary care.
Address endocrine dysfunctions identified via ICD-coded diagnoses and clinical documentation.
Monitoring & Follow-up
Conduct longitudinal follow-up of neurobehavioral and neurocognitive outcomes post-treatment.
Regularly assess mental wellbeing of PBTS and their families through surveys and clinical evaluations.
Risks
Cranial radiation therapy dosage and volume irradiated increase risk of neurocognitive and neurobehavioral impairments.
Younger age at treatment and longer remission duration are associated with worse outcomes.
Genetic predisposition may increase susceptibility to neurobehavioral declines.
Endocrine dysfunctions contribute to neurobehavioral sequelae.
Patient & Prescribing Data
Survivors of pediatric brain tumors with completed treatment and no recurrence
Treatment-related factors such as cranial radiation therapy parameters and endocrine sequelae influence neurobehavioral outcomes; multidisciplinary management is essential.
Clinical Best Practices
Use standardized diagnostic criteria and validated tools for neurobehavioral assessments in PBTS.
Incorporate multidisciplinary teams including oncologists, psychiatrists, psychologists, and endocrinologists for comprehensive care.
Implement long-term follow-up protocols to monitor neurobehavioral and neurocognitive sequelae.
Educate families about potential neurobehavioral risks and support needs post-treatment.
by Yuliang Wang, Wing Lam Chan, Fei Li, Jiaoyang Cai, Yin Ting Cheung, Eric Tsz Him Lai, Oscar Lok Kan Leung, Shiting Liang, Dennis Tak Loi Ku, Matthew Ming Kong Shing, Eric Chun Ho Fu, Jeffrey Ping Wa Yau, Anselm Chi Wai Lee, Evelyn Ruoyun Lu, Alex Wing Kwan Leung, Frankie Wai Tsoi Cheng, Wilson Wai Shing Ho, Zeng Gao, Ye Song, Stephenie Ka Yee Liu, Lucia Tsang, Ada Nga Yee Yuen, Tatia Mei Chun Lee, Godfrey Chi Fung Chan, Anthony Pak Yin Liu, Winnie Wan Yee Tso
